Le Lézard
Classified in: Health, Business
Subjects: NPT, CHI, CXP

Gillette Children's Rebrands as a Global Beacon for Brain, Bone, and Movement Conditions


Gillette Children's redefines what is possible for children with complex, rare, and traumatic conditions through clinical leadership, research, and global advocacy.

ST. PAUL, Minn., May 16, 2022 /PRNewswire/ -- Today, Gillette Children's Specialty Healthcare launches Gillette Children's, a simplified name and refreshed brand that redefines its world-class capabilities in brain, bone, and movement conditions that start in childhood.

The independent, not-for-profit health care system will go by the name Gillette Children's. This comes as the hospital celebrates 125 years of excellence. Along with the updated brand, Gillette Children's is expanding its campus, improving digital health, continuing innovative research and advocating to achieve equitable health care for all children.

"Gillette Children's brand shapes our future," said Barbara Joers, President and CEO. "Though Gillette's brand has changed, our commitment to our patients and families is unwavering. We help patients create their own story and redefine what is possible so that they can achieve their goals. We relentlessly pursue innovative research and new models of clinical care to improve the lives of children." 

Construction crews are completing an expansion on Gillette Children's St. Paul campus that will allow for expanded clinical space, easier access to Gillette Children's and more parking. The structure, called the Gateway Plaza, will include a new welcome center as well as a covered outdoor play area with an inclusive playground.

Physicians across the nation and world refer children to Gillette Children's. Patients and families come to Gillette Children's from every county in Minnesota, nearly every state and multiple countries. The acuity of Gillette's patients is one of the highest of all independent children's hospitals in America.

Gillette Children's is one of a few pediatric specialty programs in Minnesota accredited by the Commission on the Accreditation of Rehabilitation Facilities (CARF) to meet the needs of young children and adolescents seeking acute inpatient rehabilitation to recover from brain injury, stroke or spinal cord injury. Gillette is one of less than 10 U. S. pediatric inpatient rehabilitation facilities to have CARF accreditation for both pediatric specialty and pediatric brain injury programs. Gillette Children's operates Minnesota's first Level 1 Pediatric Trauma Center, providing the highest level of care possible for injured children and teens.

Although Gillette Children's has a refreshed name and look, our mission remains remarkably constant. We envision a world in which every child can create their own story, and our mission is to collaborate with patients, families and medical partners to redefine what's possible for children with brain, bone and movement conditions through clinical leadership, research and global advocacy.

About Gillette Children's
Founded in 1897, Gillette Children's is a global beacon of care for patients with brain, bone and movement conditions that start in childhood. Our research, treatment and supportive technologies enable every child to lead a full life defined by their dreams, not their diagnoses. To learn more, visit gillettechildrens.org.

SOURCE Gillette Children's


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: